SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
CNXU

Conexeu Sciences Inc. (CNXU)

NASDAQ: CNXU · USD
Healthcare · Biotechnology
$2.35+$0.35 (+17.75%)
 
Market cap
$72.6M
Insider Score
Market Cap$72.61M-82.5%
Revenue (ttm)n/a
Net Income-$13.63M
EPS-$0.61
Shares Out30.83M
PE Ration/a
Forward PE-4.44
Dividendn/a
Ex-Dividend Daten/a
Volume432,429
Open$2.08
Previous Close$2.00
Day's Range$2.00 - $2.35
52-Week Range$1.93 - $18.79
Betan/a
Analystsnone
Price Target$20.00(+749.26%)
Earnings DateJan 22, 2027

About CNXU

Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. The company provides patented collagen-based scaffold products, including a collagen extracellular matrix (ECM) scaffold platform for use in medical aesthetics, wound care, tissue repair, facial rejuvenation, and large-volume body contouring such as face, breast, and butt volume restoration. Its CXU collagen gel is an investigational product targeting therapeutic and aesthetic indications, supporting tissue regeneration and aiming to minimize inflammation or fibrosis. The company's solutions are supported by preclinical and peer-reviewed data and are positioned as alternatives to conventional fillers or implants, with products currently investigational and pending regulatory clearance for certain applications. The company serves clients in the beauty, aesthetics, regenerative medicine, and medical sectors, including clinicians and professionals involved in facial rejuvenation, body contouring, wound care, and tissue repair. The company was founded in 2022 and is based in Reno, Nevada.

Address
50 West Liberty Street, Reno, NV, 89501, United States
Market Cap
73 million
Employees
—
Industrial Classification
Biotechnology

Conexeu Sciences Inc. Stock Analysis — InsiderScore

Insider Score
See top-rated InsiderScore stocks ›
41st Percentile Overall Score
CNXU InsiderScore:65 / 99

Conexeu Sciences Inc. scored higher than 41% of companies evaluated by InsiderBuying, and ranked 48th out of 103 stocks in the biotech sector.

Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.

Dollars Committed

Insiders at Conexeu Sciences Inc. bought $500.0K of stock across 1 purchase in the last 90 days, the largest of them $500.0K.

Stake Increase

The average purchase added about 6% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.

New Positions

Every buyer already held stock, so each purchase is an increase rather than a first position.

This category carries 35% of the Insider Score.

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$1.34M

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

When insiders bought and sold

1 year · open-market trades only
Closing Price Purchase Sale
$1.84$9.77$17.69JunAugOct

Next catalysts

1 Day
+18.00%
5 Days
+4.42%
1 Month
-21.07%
6 Months
-81.94%
1 Year
-82.52%

$CNXU stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in CNXU holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by CNXU's directors and management

Net Shares Purchased by Insiders−2M−1M02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

CNXU Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New CNXU patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to CNXU from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from CNXU’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
60% of score
50.22
Analyst Ratings
40% of score
60
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
4
Sells
0
Buy Value
$1.34M
Distinct Buyers
2

Insider Score Trend Over Time

-14.6 since Oct 20
0255075100Oct 20 — Insider Score 77.8Oct 21 — Insider Score 77.6Oct 22 — Insider Score 77.8Oct 23 — Insider Score 77.7Oct 24 — Insider Score 77.6Oct 25 — Insider Score 77.3Oct 26 — Insider Score 77.2Oct 27 — Insider Score 77.2Oct 28 — Insider Score 77.0Oct 29 — Insider Score 76.5Oct 30 — Insider Score 75.3Oct 31 — Insider Score 75.0Nov 1 — Insider Score 75.2Nov 2 — Insider Score 75.2Nov 3 — Insider Score 74.3Nov 4 — Insider Score 73.6Nov 5 — Insider Score 72.9Nov 6 — Insider Score 71.9Nov 7 — Insider Score 71.3Nov 8 — Insider Score 71.8Nov 9 — Insider Score 72.1Nov 10 — Insider Score 70.5Nov 11 — Insider Score 69.6Nov 12 — Insider Score 69.0Nov 13 — Insider Score 67.7Nov 14 — Insider Score 66.6Nov 15 — Insider Score 67.2Nov 16 — Insider Score 66.9Nov 17 — Insider Score 65.5Nov 18 — Insider Score 64.3Nov 19 — Insider Score 63.2Oct 20Nov 4Nov 19

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.